Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dodick

Showing results (411-420 of 620) with videos related to

Pageof 62
Sort By:
The Journal of Investigative Dermatology|April 1, 1993
Pigmentation and inhibition of wound contraction by cultured skin substitutes with adult melanocytes after transplantation to athymic miceS T Boyce, E E Medrano, Z Abdel-Malek, et al.
Cephalalgia : an International Journal of Headache|August 15, 2020
[<sup>123</sup>I]-IMP single-photon emission computed tomography imaging in visual snow syndrome: A case seriesMamoru Shibata, Kei Tsutsumi, Yu Iwabuchi, et al.
The Journal of Headache and Pain|April 26, 2022
Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trialsRichard B Lipton, Rashmi B Halker Singh, Dennis A Revicki, et al.
Mayo Clinic Proceedings|January 5, 2024
Pharmacotherapies for Migraine and Translating Evidence From Bench to BedsideMessoud Ashina, Jan Hoffmann, Håkan Ashina, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 16, 2014
Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPTStephen D Silberstein, David W Dodick, Sheena K Aurora, et al.
The Lancet. Neurology|June 9, 2019
Pathophysiology, prevention, and treatment of medication overuse headacheHans-Christoph Diener, David Dodick, Stefan Evers, et al.
Cephalalgia : an International Journal of Headache|June 26, 2020
Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headacheJill C Rau, Edita Navratilova, Janice Oyarzo, et al.
Cephalalgia : an International Journal of Headache|January 15, 2025
Prolactin-induced sensitization of trigeminal nociceptors promotes migraine co-morbidity in endometriosisGrace J Lee, Veronica Hode, Teodora Georgieva, et al.
Brain Communications|March 6, 2024
Unraveling the directional relationship of sleep and migraine-like painRobson C Lillo Vizin, Caroline M Kopruszinski, Paula M Redman, et al.
Headache|February 6, 2021
Real-world efficacy, tolerability, and safety of ubrogepantChia-Chun Chiang, Karissa N Arca, Rachel B Dunn, et al.
Pageof 62

Showing results (411-420 of 620) with videos related to

Sort By:
Pageof 62
The Journal of Investigative Dermatology|April 1, 1993
Pigmentation and inhibition of wound contraction by cultured skin substitutes with adult melanocytes after transplantation to athymic miceS T Boyce, E E Medrano, Z Abdel-Malek, et al.
Cephalalgia : an International Journal of Headache|August 15, 2020
[<sup>123</sup>I]-IMP single-photon emission computed tomography imaging in visual snow syndrome: A case seriesMamoru Shibata, Kei Tsutsumi, Yu Iwabuchi, et al.
The Journal of Headache and Pain|April 26, 2022
Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trialsRichard B Lipton, Rashmi B Halker Singh, Dennis A Revicki, et al.
Mayo Clinic Proceedings|January 5, 2024
Pharmacotherapies for Migraine and Translating Evidence From Bench to BedsideMessoud Ashina, Jan Hoffmann, Håkan Ashina, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 16, 2014
Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPTStephen D Silberstein, David W Dodick, Sheena K Aurora, et al.
The Lancet. Neurology|June 9, 2019
Pathophysiology, prevention, and treatment of medication overuse headacheHans-Christoph Diener, David Dodick, Stefan Evers, et al.
Cephalalgia : an International Journal of Headache|June 26, 2020
Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headacheJill C Rau, Edita Navratilova, Janice Oyarzo, et al.
Cephalalgia : an International Journal of Headache|January 15, 2025
Prolactin-induced sensitization of trigeminal nociceptors promotes migraine co-morbidity in endometriosisGrace J Lee, Veronica Hode, Teodora Georgieva, et al.
Brain Communications|March 6, 2024
Unraveling the directional relationship of sleep and migraine-like painRobson C Lillo Vizin, Caroline M Kopruszinski, Paula M Redman, et al.
Headache|February 6, 2021
Real-world efficacy, tolerability, and safety of ubrogepantChia-Chun Chiang, Karissa N Arca, Rachel B Dunn, et al.
Pageof 62